Беринерт

Беринерт contains C1 Esterase Inhibitor (Human) for managing hereditary angioedema (HAE) attacks. This intravenous therapy helps regulate immune responses. Suitable for patients with confirmed HAE type I or II. Short-term use for acute symptom relief.

C1 Esterase Inhibitor (Human) is used to treat acute episodes of hereditary angioedema (HAE), a rare genetic condition causing sudden swelling. It works by replacing the missing or dysfunctional protein that controls inflammation. Healthcare providers may also use it for routine prevention in certain cases. This medication is not a cure but helps manage symptoms during flare-ups.

After administration, the inhibitor helps reduce swelling and discomfort associated with HAE attacks. Users may notice symptom improvement within hours. The effect varies by individual and severity of the episode. Regular use is not typically required unless prescribed for prevention.

Store Беринерт refrigerated between 2°C and 8°C (36°F–46°F) and protect from light. Do not freeze. Use only if the solution is clear and free of particles. Discard any unused portion after opening. Always follow healthcare provider instructions for handling and disposal.

No specific drug interactions are widely documented, but always inform your provider about all medications, including over-the-counter and supplements. Caution is advised when combining with other therapies affecting blood clotting or immune response. Alcohol and certain foods may influence effectiveness—consult a healthcare professional for guidance.